Table of Contents Author Guidelines Submit a Manuscript
Journal of Aging Research
Volume 2011, Article ID 617927, 13 pages
http://dx.doi.org/10.4061/2011/617927
Review Article

Age-Related White Matter Changes

Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong Special Administrative Region, Shatin 999077, Hong Kong

Received 5 May 2011; Revised 28 June 2011; Accepted 28 June 2011

Academic Editor: Leonardo Pantoni

Copyright © 2011 Yun Yun Xiong and Vincent Mok. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. L. Pantoni, “Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges,” The Lancet Neurology, vol. 9, no. 7, pp. 689–701, 2010. View at Publisher · View at Google Scholar · View at Scopus
  2. W. T. Longstreth Jr., T. A. Manolio, A. Arnold et al., “Clinical correlates of white matter findings on cranial magnetic resonance imaging of 3301 elderly people: the cardiovascular health study,” Stroke, vol. 27, no. 8, pp. 1274–1282, 1996. View at Google Scholar · View at Scopus
  3. D. Liao, L. Cooper, J. Cai et al., “Presence and severity of cerebral white matter lesions and hypertension, its treatment, and its control: the ARIC study,” Stroke, vol. 27, no. 12, pp. 2262–2270, 1996. View at Google Scholar · View at Scopus
  4. F. E. de Leeuw, J. C. de Groot, E. Achten et al., “Prevalence of cerebral white matter lesions in elderly people: a population based magnetic resonance imaging study. The Rotterdam Scan Study,” Journal of Neurology Neurosurgery and Psychiatry, vol. 70, no. 1, pp. 9–14, 2001. View at Publisher · View at Google Scholar · View at Scopus
  5. W. Wen, P. S. Sachdev, J. J. Li, X. Chen, and K. J. Anstey, “White matter hyperintensities in the forties: their prevalence and topography in an epidemiological sample aged 44–48,” Human Brain Mapping, vol. 30, no. 4, pp. 1155–1167, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  6. L. J. Launer, K. Berger, M. M. B. Breteler et al., “Regional variability in the prevalence of cerebral white matter lesions: an MRI study in 9 European countries (CASCADE),” Neuroepidemiology, vol. 26, no. 1, pp. 23–29, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  7. R. Mantyla, H. J. Aronen, O. Salonen et al., “The prevalence and distribution of white-matter changes on different MRI pulse sequences in a post-stroke cohort,” Neuroradiology, vol. 41, no. 9, pp. 657–665, 1999. View at Publisher · View at Google Scholar · View at Scopus
  8. J. H. Fu, C. Z. Lu, Z. Hong, Q. Dong, Y. Luo, and K. S. Wong, “Extent of white matter lesions is related to acute subcortical infarcts and predicts further stroke risk in patients with first ever ischaemic stroke,” Journal of Neurology, Neurosurgery and Psychiatry, vol. 76, no. 6, pp. 793–796, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  9. W. K. Tang, S. S. Chan, H. F. Chiu et al., “Frequency and determinants of poststroke dementia in Chinese,” Stroke, vol. 35, no. 4, pp. 930–935, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  10. J. Jimenez-Conde, A. Biffi, R. Rahman et al., “Hyperlipidemia and reduced white matter hyperintensity volume in patients with ischemic stroke,” Stroke, vol. 41, no. 3, pp. 437–442, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  11. J. Aharon-Peretz, J. L. Cummings, and M. A. Hill, “Vascular dementia and dementia of the Alzheimer type. Cognition, ventricular size, and leuko-araiosis,” Archives of Neurology, vol. 45, no. 7, pp. 719–721, 1988. View at Google Scholar · View at Scopus
  12. F. E. de Leeuw, F. Barkhof, and P. Scheltens, “White matter lesions and hippocampal atrophy in Alzheimer's disease,” Neurology, vol. 62, no. 2, pp. 310–312, 2004. View at Google Scholar · View at Scopus
  13. M. Targosz-Gajniak, J. Siuda, S. Ochudlo, and G. Opala, “Cerebral white matter lesions in patients with dementia—from MCI to severe Alzheimer's disease,” Journal of the Neurological Sciences, vol. 283, no. 1-2, pp. 79–82, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  14. S. J. Lee, J. S. Kim, K. S. Lee et al., “The severity of leukoaraiosis correlates with the clinical phenotype of Parkinson's disease,” Archives of Gerontology and Geriatrics, vol. 49, no. 2, pp. 255–259, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  15. J. Slawek, D. Wieczorek, M. Derejko et al., “The influence of vascular risk factors and white matter hyperintensities on the degree of cognitive impairment in Parkinson's disease,” Neurologia i Neurochirurgia Polska, vol. 42, no. 6, pp. 505–512, 2008. View at Google Scholar
  16. Y. H. Sohn and J. S. Kim, “The influence of white matter hyperintensities on the clinical features of parkinson's disease,” Yonsei Medical Journal, vol. 39, no. 1, pp. 50–55, 1998. View at Google Scholar · View at Scopus
  17. H. S. Jorgensen, H. Nakayama, H. O. Raaschou, and T. S. Olsen, “Leukoaraiosis in stroke patients: the Copenhagen stroke study,” Stroke, vol. 26, no. 4, pp. 588–592, 1995. View at Google Scholar · View at Scopus
  18. D. Liao, L. Cooper, J. Cai et al., “The prevalence and severity of white matter lesions, their relationship with age, ethnicity, gender, and cardiovascular disease risk factors: the ARIC study,” Neuroepidemiology, vol. 16, no. 3, pp. 149–162, 1997. View at Google Scholar · View at Scopus
  19. H. Henon, O. Godefroy, C. Lucas, J. P. Pruvo, and D. Leys, “Risk factors and leukoaraiosis in stroke patients,” Acta Neurologica Scandinavica, vol. 94, no. 2, pp. 137–144, 1996. View at Google Scholar
  20. A. M. Basile, L. Pantoni, G. Pracucci et al., “Age, hypertension, and lacunar stroke are the major determinants of the severity of age-related white matter changes. The LADIS (Leukoaraiosis and Disability in the Elderly) study,” Cerebrovascular Diseases, vol. 21, no. 5-6, pp. 315–322, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  21. J. C. van Swieten, G. G. Geyskes, M. M. Derix et al., “Hypertension in the elderly is associated with white matter lesions and cognitive decline,” Annals of Neurology, vol. 30, no. 6, pp. 825–830, 1991. View at Google Scholar · View at Scopus
  22. H. S. Choi, Y. M. Cho, J. H. Kang, C. S. Shin, K. S. Park, and H. K. Lee, “Cerebral white matter hyperintensity is mainly associated with hypertension among the components of metabolic syndrome in Koreans,” Clinical Endocrinology, vol. 71, no. 2, pp. 184–188, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  23. M. K. Park, I. Jo, M. H. Park, T. K. Kim, S. A. Jo, and C. Shin, “Cerebral white matter lesions and hypertension status in the elderly Korean: the Ansan Study,” Archives of Gerontology and Geriatrics, vol. 40, no. 3, pp. 265–273, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  24. E. J. van Dijk, M. M. Breteler, R. Schmidt et al., “The association between blood pressure, hypertension, and cerebral white matter lesions: cardiovascular determinants of dementia study,” Hypertension, vol. 44, no. 5, pp. 625–630, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  25. F. E. de Leeuw, J. C. de Groot, M. Oudkerk et al., “Hypertension and cerebral white matter lesions in a prospective cohort study,” Brain, vol. 125, no. 4, pp. 765–772, 2002. View at Google Scholar · View at Scopus
  26. C. Sierra, “Cerebral white matter lesions in essential hypertension,” Current Hypertension Reports, vol. 3, no. 5, pp. 429–433, 2001. View at Google Scholar · View at Scopus
  27. L. H. Kuller, K. L. Margolis, S. A. Gaussoin et al., “Relationship of hypertension, blood pressure, and blood pressure control with white matter abnormalities in the Women's Health Initiative Memory Study (WHIMS)—MRI trial,” Journal of Clinical Hypertension, vol. 12, no. 3, pp. 203–212, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  28. C. Dufouil, A. de Kersaint-Gilly, V. Besancon et al., “Longitudinal study of blood pressure and white matter hyperintensities: the EVA MRI cohort,” Neurology, vol. 56, no. 7, pp. 921–926, 2001. View at Google Scholar · View at Scopus
  29. T. Jeerakathil, P. A. Wolf, A. Beiser et al., “Stroke risk profile predicts white matter hyperintensity volume: the Framingham study,” Stroke, vol. 35, no. 8, pp. 1857–1861, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  30. M. Vuorinen, A. Solomon, S. Rovio et al., “Changes in vascular risk factors from midlife to late life and white matter lesions: a 20-year follow-up study,” Dementia and Geriatric Cognitive Disorders, vol. 31, no. 2, pp. 119–125, 2011. View at Publisher · View at Google Scholar · View at PubMed
  31. A. M. Brickman, C. Reitz, J. A. Luchsinger et al., “Long-term blood pressure fluctuation and cerebrovascular disease in an elderly cohort,” Archives of Neurology, vol. 67, no. 5, pp. 564–569, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  32. D. Carmelli, C. DeCarli, G. E. Swan et al., “Evidence for genetic variance in white matter hyperintensity volume in normal elderly male twins,” Stroke, vol. 29, no. 6, pp. 1177–1181, 1998. View at Google Scholar · View at Scopus
  33. F. E. de Leeuw, F. Richard, J. C. de Groot et al., “Interaction between hypertension, apoE, and cerebral white matter lesions,” Stroke, vol. 35, no. 5, pp. 1057–1060, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  34. K. Kohara, M. Fujisawa, F. Ando et al., “MTHFR gene polymorphism as a risk factor for silent brain infarcts and white matter lesions in the Japanese general population: the NILS-LSA study,” Stroke, vol. 34, no. 5, pp. 1130–1135, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  35. L. H. Henskens, A. A. Kroon, M. P. van Boxtel, P. A. Hofman, and P. W. De Leeuw, “Associations of the angiotensin II type 1 receptor A1166C and the endothelial NO synthase G894T gene polymorphisms with silent subcortical white matter lesions in essential hypertension,” Stroke, vol. 36, no. 9, pp. 1869–1873, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  36. L. Paternoster, W. Chen, and C. L. Sudlow, “Genetic determinants of white matter hyperintensities on brain scans: a systematic assessment of 19 candidate gene polymorphisms in 46 studies in 19,000 subjects,” Stroke, vol. 40, no. 6, pp. 2020–2026, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  37. L. J. Podewils, E. Guallar, N. Beauchamp, C. G. Lyketsos, L. H. Kuller, and P. Scheltens, “Physical activity and white matter lesion progression: assessment using MRI,” Neurology, vol. 68, no. 15, pp. 1223–1226, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  38. V. C. Mok, W. W. Lam, Y. H. Fan et al., “Effects of statins on the progression of cerebral white matter lesion : post hoc analysis of the ROCAS (Regression of Cerebral Artery Stenosis) study,” Journal of Neurology, vol. 256, no. 5, pp. 750–757, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  39. A. A. Gouw, W. M. van der Flier, F. Fazekas et al., “Progression of white matter hyperintensities and incidence of new lacunes over a 3-year period: the leukoaraiosis and disability study,” Stroke, vol. 39, no. 5, pp. 1414–1420, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  40. L. O. Wahlund, O. Almkvist, H. Basun, and P. Julin, “MRI in successful aging, a 5-year follow-up study from the eighth to ninth decade of life,” Magnetic Resonance Imaging, vol. 14, no. 6, pp. 601–608, 1996. View at Publisher · View at Google Scholar · View at Scopus
  41. J. H. Veldink, P. Scheltens, C. Jonker, and L. J. Launer, “Progression of cerebral white matter hyperintensities on MRI is related to diastolic blood pressure,” Neurology, vol. 51, no. 1, pp. 319–320, 1998. View at Google Scholar · View at Scopus
  42. R. Schmidt, F. Fazekas, P. Kapeller, H. Schmidt, and H. P. Hartung, “MRI white matter hyperintensities: three-year follow-up of the Austrian Stroke Prevention Study,” Neurology, vol. 53, no. 1, pp. 132–139, 1999. View at Google Scholar · View at Scopus
  43. G. T. Whitman, T. Tang, A. Lin, and R. W. Baloh, “A prospective study of cerebral white matter abnormalities in older people with gait dysfunction,” Neurology, vol. 57, no. 6, pp. 990–994, 2001. View at Google Scholar · View at Scopus
  44. R. Schmidt, C. Enzinger, S. Ropele, H. Schmidt, and F. Fazekas, “Progression of cerebral white matter lesions: 6-Year results of the Austrian Stroke Prevention Study,” The Lancet, vol. 361, no. 9374, pp. 2046–2048, 2003. View at Publisher · View at Google Scholar · View at Scopus
  45. W. D. Taylor, D. C. Steffens, J. R. MacFall et al., “White matter hyperintensity progression and late-life depression outcomes,” Archives of General Psychiatry, vol. 60, no. 11, pp. 1090–1096, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  46. J. Y. Streifler, M. Eliasziw, O. R. Benavente et al., “Development and progression of leukoaraiosis in patients with brain ischemia and carotid artery disease,” Stroke, vol. 34, no. 8, pp. 1913–1916, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  47. P. Sachdev, W. Wen, X. Chen, and H. Brodaty, “Progression of white matter hyperintensities in elderly individuals over 3 years,” Neurology, vol. 68, no. 3, pp. 214–222, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  48. E. J. van Dijk, N. D. Prins, H. A. Vrooman, A. Hofman, P. J. Koudstaal, and M. M. Breteler, “Progression of cerebral small vessel disease in relation to risk factors and cognitive consequences: Rotterdam Scan study,” Stroke, vol. 39, no. 10, pp. 2712–2719, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  49. R. Schmidt, P. Scheltens, T. Erkinjuntti et al., “White matter lesion progression: a surrogate endpoint for trials in cerebral small-vessel disease,” Neurology, vol. 63, no. 1, pp. 139–144, 2004. View at Google Scholar · View at Scopus
  50. E. J. Burton, I. G. McKeith, D. J. Burn, M. J. Firbank, and J. T. O'Brien, “Progression of white matter hyperintensities in Alzheimer disease, dementia with lewy bodies, and Parkinson disease dementia: a comparison with normal aging,” American Journal of Geriatric Psychiatry, vol. 14, no. 10, pp. 842–849, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  51. D. M. van den Heuvel, F. Admiraal-Behloul, V. H. ten Dam et al., “Different progression rates for deep white matter hyperintensities in elderly men and women,” Neurology, vol. 63, no. 9, pp. 1699–1701, 2004. View at Google Scholar · View at Scopus
  52. A. Brun and E. Englund, “A white matter disorder in dementia of the Alzheimer type: a pathoanatomical study,” Annals of Neurology, vol. 19, no. 3, pp. 253–262, 1986. View at Google Scholar · View at Scopus
  53. L. Pantoni, “Pathophysiology of age-related cerebral white matter changes,” Cerebrovascular Diseases, vol. 13, supplement 2, pp. 7–10, 2002. View at Google Scholar · View at Scopus
  54. L. Pantoni, D. Inzitari, G. Pracucci et al., “Cerebrospinal fluid proteins in patients with leucaraiosis: possible abnormalities in blood-brain barrier function,” Journal of the Neurological Sciences, vol. 115, no. 2, pp. 125–131, 1993. View at Publisher · View at Google Scholar · View at Scopus
  55. A. Wallin, M. Sjogren, A. Edman, K. Blennow, and B. Regland, “Symptoms, vascular risk factors and blood-brain barrier function in relation to CT white-matter changes in dementia,” European Neurology, vol. 44, no. 4, pp. 229–235, 2000. View at Google Scholar · View at Scopus
  56. R. Topakian, T. R. Barrick, F. A. Howe, and H. S. Markus, “Blood-brain barrier permeability is increased in normal-appearing white matter in patients with lacunar stroke and leucoaraiosis,” Journal of Neurology, Neurosurgery and Psychiatry, vol. 81, no. 2, pp. 192–197, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  57. J. E. Simpson, S. B. Wharton, J. Cooper et al., “Alterations of the blood-brain barrier in cerebral white matter lesions in the ageing brain,” Neuroscience Letters, vol. 486, no. 3, pp. 246–251, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  58. F. Fazekas, R. Kleinert, H. Olfenbacher et al., “Pathologic correlates of incidental MRI white matter signal hyperintensities,” Neurology, vol. 43, no. 9, pp. 1683–1689, 1993. View at Google Scholar · View at Scopus
  59. J. E. Simpson, P. G. Ince, C. E. Higham et al., “Microglial activation in white matter lesions and nonlesional white matter of ageing brains,” Neuropathology and Applied Neurobiology, vol. 33, no. 6, pp. 670–683, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  60. L. Pantoni and J. H. Garcia, “The significance of cerebral white matter abnormalities 100 years after Binswanger's report: a review,” Stroke, vol. 26, no. 7, pp. 1293–1301, 1995. View at Google Scholar · View at Scopus
  61. S. M. Manschot, G. J. Biessels, G. E. Rutten, R. P. Kessels, W. H. Gispen, and L. J. Kappelle, “Peripheral and central neurologic complications in type 2 diabetes mellitus: no association in individual patients,” Journal of the Neurological Sciences, vol. 264, pp. 157–162, 2008. View at Google Scholar
  62. V. Novak, D. Last, D. C. Alsop et al., “Cerebral blood flow velocity and periventricular white matter hyperintensities in type 2 diabetes,” Diabetes Care, vol. 29, no. 7, pp. 1529–1534, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  63. J. E. Simpson, O. Hosny, S. B. Wharton et al., “Microarray RNA expression analysis of cerebral white matter lesions reveals changes in multiple functional pathways,” Stroke, vol. 40, no. 2, pp. 369–375, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  64. H. Xu, B. Stamova, G. Jickling et al., “Distinctive RNA expression profiles in blood associated with white matter hyperintensities in brain,” Stroke, vol. 41, no. 12, pp. 2744–2749, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  65. J. H. Fu, C. Z. Lu, Z. Hong, Q. Dong, D. Ding, and K. S. Wong, “Relationship between cerebral vasomotor reactivity and white matter lesions in elderly subjects without large artery occlusive disease,” Journal of Neuroimaging, vol. 16, no. 2, pp. 120–125, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  66. Y. Isaka, M. Okamoto, K. Ashida, and M. Imaizumi, “Decreased cerebrovascular dilatory capacity in subjects with asymptomatic periventricular hyperintensities,” Stroke, vol. 25, no. 2, pp. 375–381, 1994. View at Google Scholar · View at Scopus
  67. S. L. Bakker, F. E. de Leeuw, J. C. de Groot, A. Hofman, P. J. Koudstaal, and M. M. Breteler, “Cerebral vasomotor reactivity and cerebral white matter lesions in the elderly,” Neurology, vol. 52, no. 3, pp. 578–583, 1999. View at Google Scholar · View at Scopus
  68. R. Ohtani, H. Tomimoto, T. Kawasaki et al., “Cerebral vasomotor reactivity to postural change is impaired in patients with cerebrovascular white matter lesions,” Journal of Neurology, vol. 250, no. 4, pp. 412–417, 2003. View at Publisher · View at Google Scholar · View at PubMed
  69. G. M. Kozera, M. Dubaniewicz, T. Zdrojewski et al., “Cerebral vasomotor reactivity and extent of white matter lesions in middle-aged men with arterial hypertension: a pilot study,” American Journal of Hypertension, vol. 23, no. 11, pp. 1198–1203, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  70. C. P. Chung and H. H. Hu, “Pathogenesis of leukoaraiosis: role of jugular venous reflux,” Medical Hypotheses, vol. 75, no. 1, pp. 85–90, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  71. L. Pantoni and J. H. Garcia, “Pathogenesis of leukoaraiosis: a review,” Stroke, vol. 28, no. 3, pp. 652–659, 1997. View at Google Scholar · View at Scopus
  72. W. R. Brown, D. M. Moody, C. R. Thore, and V. R. Challa, “Apoptosis in leukoaraiosis,” American Journal of Neuroradiology, vol. 21, no. 1, pp. 79–82, 2000. View at Google Scholar · View at Scopus
  73. G. Jickling, A. Salam, A. Mohammad et al., “Circulating endothelial progenitor cells and age-related white matter changes,” Stroke, vol. 40, no. 10, pp. 3191–3196, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  74. A. Hassan, B. J. Hunt, M. O'Sullivan et al., “Markers of endothelial dysfunction in lacunar infarction and ischaemic leukoaraiosis,” Brain, vol. 126, no. 2, pp. 424–432, 2003. View at Publisher · View at Google Scholar · View at Scopus
  75. J. C. de Groot, F. E. de Leeuw, M. Oudkerk et al., “Cerebral white matter lesions and cognitive function: the Rotterdam Scan study,” Annals of Neurology, vol. 47, no. 2, pp. 145–151, 2000. View at Publisher · View at Google Scholar · View at Scopus
  76. D. K. Jones, D. Lythgoe, M. A. Horsfield, A. Simmons, S. C. Williams, and H. S. Markus, “Characterization of white matter damage in ischemic leukoaraiosis with diffusion tensor MRI,” Stroke, vol. 30, no. 2, pp. 393–397, 1999. View at Google Scholar · View at Scopus
  77. A. Nitkunan, T. R. Barrick, R. A. Charlton, C. A. Clark, and H. S. Markus, “Multimodal MRI in cerebral small vessel disease: its relationship with cognition and sensitivity to change over time,” Stroke, vol. 39, no. 7, pp. 1999–2005, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  78. F. Fazekas, F. Barkhof, L. O. Wahlund et al., “CT and MRI rating of white matter lesions,” Cerebrovascular Diseases, vol. 13, supplement 2, pp. 31–36, 2002. View at Google Scholar · View at Scopus
  79. F. Fazekas, J. B. Chawluk, A. Alavi, H. I. Hurtig, and R. A. Zimmerman, “MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging,” American Journal of Roentgenology, vol. 149, no. 2, pp. 351–356, 1987. View at Google Scholar
  80. P. Scheltens, F. Barkhof, D. Leys et al., “A semiquantitative rating scale for the assessment of signal hyperintensities on magnetic resonance imaging,” Journal of the Neurological Sciences, vol. 114, no. 1, pp. 7–12, 1993. View at Publisher · View at Google Scholar · View at Scopus
  81. L. O. Wahlund, F. Barkhof, F. Fazekas et al., “A new rating scale for age-related white matter changes applicable to MRI and CT,” Stroke, vol. 32, no. 6, pp. 1318–1322, 2001. View at Google Scholar · View at Scopus
  82. V. Hachinski, C. Iadecola, R. C. Petersen et al., “National Institute of Neurological Disorders and Stroke-Canadian Stroke Network vascular cognitive impairment harmonization standards,” Stroke, vol. 37, no. 9, pp. 2220–2241, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  83. Y. Xiong, V. Mok, A. Wong et al., “The age-related white matter changes scale correlates with cognitive impairment,” European Journal of Neurology, vol. 17, no. 12, pp. 1451–1456, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  84. Y. Xiong, J. Yang, A. Wong et al., “Operational definitions improve reliability of the age-related white matter changes scale,” European Journal of Neurology, vol. 18, no. 5, pp. 744–749, 2011. View at Publisher · View at Google Scholar · View at PubMed
  85. N. D. Prins, E. C. van Straaten, E. J. van Dijk et al., “Measuring progression of cerebral white matter lesions on MRI: visual rating and volumetrics,” Neurology, vol. 62, no. 9, pp. 1533–1539, 2004. View at Google Scholar · View at Scopus
  86. A. A. Gouw, W. M. van der Flier, E. C. van Straaten et al., “Reliability and sensitivity of visual scales versus volumetry for evaluating white matter hyperintensity progression,” Cerebrovascular Diseases, vol. 25, no. 3, pp. 247–253, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  87. N. D. Prins, E. J. van Dijk, T. den Heijer et al., “Cerebral small-vessel disease and decline in information processing speed, executive function and memory,” Brain, vol. 128, no. 9, pp. 2034–2041, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  88. V. C. Mok, A. Wong, W. W. Lam et al., “Cognitive impairment and functional outcome after stroke associated with small vessel disease,” Journal of Neurology, Neurosurgery and Psychiatry, vol. 75, no. 4, pp. 560–566, 2004. View at Publisher · View at Google Scholar · View at Scopus
  89. C. Junque, J. Pujol, P. Vendrell et al., “Leuko-araiosis on magnetic resonance imaging and speed of mental processing,” Archives of Neurology, vol. 47, no. 2, pp. 151–156, 1990. View at Google Scholar · View at Scopus
  90. R. Ylikoski, A. Ylikoski, T. Erkinjuntti, R. Sulkava, R. Raininko, and R. Tilvis, “White matter changes in healthy elderly persons correlate with attention and speed of mental processing,” Archives of Neurology, vol. 50, no. 8, pp. 818–824, 1993. View at Google Scholar · View at Scopus
  91. W. M. van der Flier, E. C. Van Straaten, F. Barkhof et al., “Small vessel disease and general cognitive function in nondisabled elderly: the LADIS study,” Stroke, vol. 36, no. 10, pp. 2116–2120, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  92. S. Debette and H. S. Markus, “The clinical importance of white matter hyperintensities on brain magnetic resonance imaging: systematic review and meta-analysis,” British Medical Journal, vol. 341, Article ID c3666, 2010. View at Publisher · View at Google Scholar
  93. D. M. van den Heuvel, V. H. ten Dam, A. J. de Craen et al., “Increase in periventricular white matter hyperintensities parallels decline in mental processing speed in a non-demented elderly population,” Journal of Neurology, Neurosurgery and Psychiatry, vol. 77, no. 2, pp. 149–153, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  94. N. D. Prins, E. J. van Dijk, T. den Heijer et al., “Cerebral white matter lesions and the risk of dementia,” Archives of Neurology, vol. 61, no. 10, pp. 1531–1534, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  95. S. E. Vermeer, M. Hollander, E. J. van Dijk, A. Hofman, P. J. Koudstaal, and M. M. Breteler, “Silent brain infarcts and white matter lesions increase stroke risk in the general population: the Rotterdam Scan Study,” Stroke, vol. 34, no. 5, pp. 1126–1129, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  96. R. Schmidt, S. Ropele, C. Enzinger et al., “White matter lesion progression, brain atrophy, and cognitive decline: the Austrian stroke prevention study,” Annals of Neurology, vol. 58, no. 4, pp. 610–616, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  97. D. Mungas, B. R. Reed, W. J. Jagust et al., “Volumetric MRI predicts rate of cognitive decline related to AD and cerebrovascular disease,” Neurology, vol. 59, no. 6, pp. 867–873, 2002. View at Google Scholar · View at Scopus
  98. D. Mungas, D. Harvey, B. R. Reed et al., “Longitudinal volumetric MRI change and rate of cognitive decline,” Neurology, vol. 65, no. 4, pp. 565–571, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  99. D. Mungas, W. J. Jagust, B. R. Reed et al., “MRI predictors of cognition in subcortical ischemic vascular disease and Alzheimer's disease,” Neurology, vol. 57, no. 12, pp. 2229–2235, 2001. View at Google Scholar · View at Scopus
  100. A. T. Du, N. Schuff, L. L. Chao et al., “White matter lesions are associated with cortical atrophy more than entorhinal and hippocampal atrophy,” Neurobiology of Aging, vol. 26, no. 4, pp. 553–559, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  101. C. DeCarli, D. G. Murphy, M. Tranh et al., “The effect of white matter hyperintensity volume on brain structure, cognitive performance, and cerebral metabolism of glucose in 51 healthy adults,” Neurology, vol. 45, no. 11, pp. 2077–2084, 1995. View at Google Scholar
  102. M. Tullberg, E. Fletcher, C. DeCarli et al., “White matter lesions impair frontal lobe function regardless of their location,” Neurology, vol. 63, no. 2, pp. 246–253, 2004. View at Google Scholar
  103. C. Eckerstrom, E. Olsson, N. Klasson et al., “High white matter lesion load is associated with hippocampal atrophy in mild cognitive impairment,” Dementia and Geriatric Cognitive Disorders, vol. 31, no. 2, pp. 132–138, 2011. View at Publisher · View at Google Scholar · View at PubMed
  104. E. E. Smith, S. Egorova, D. Blacker et al., “Magnetic resonance imaging white matter hyperintensities and brain volume in the prediction of mild cognitive impairment and dementia,” Archives of Neurology, vol. 65, no. 1, pp. 94–100, 2008. View at Publisher · View at Google Scholar · View at PubMed
  105. M. W. Vernooij, M. A. Ikram, H. A. Vrooman et al., “White matter microstructural integrity and cognitive function in a general elderly population,” Archives of General Psychiatry, vol. 66, no. 5, pp. 545–553, 2009. View at Publisher · View at Google Scholar · View at PubMed
  106. A. G. van Norden, K. F. de Laat, E. J. van Dijk et al., “Diffusion tensor imaging and cognition in cerebral small vessel disease. The RUN DMC study,” Biochimica et Biophysica Acta. In press. View at Publisher · View at Google Scholar · View at PubMed
  107. K. B. Boone, B. L. Miller, I. M. Lesser et al., “Neuropsychological correlates of white-matter lesions in healthy elderly subjects: a threshold effect,” Archives of Neurology, vol. 49, no. 5, pp. 549–554, 1992. View at Google Scholar
  108. V. Mok, W. Lam, Y. Chan, and K. Wong, Poststroke Dementia and Imaging, Nova Science Publishers, 2008.
  109. S. E. Vermeer, W. T. Longstreth Jr., and P. J. Koudstaal, “Silent brain infarcts: a systematic review,” The Lancet Neurology, vol. 6, no. 7, pp. 611–619, 2007. View at Publisher · View at Google Scholar · View at PubMed
  110. J. A. Pettersen, G. Sathiyamoorthy, F. Q. Gao et al., “Microbleed topography, leukoaraiosis, and cognition in probable Alzheimer disease from the sunnybrook dementia study,” Archives of Neurology, vol. 65, no. 6, pp. 790–795, 2008. View at Publisher · View at Google Scholar · View at PubMed
  111. S. E. Vermeer, N. D. Prins, T. den Heijer, A. Hofman, P. J. Koudstaal, and M. M. Breteler, “Silent brain infarcts and the risk of dementia and cognitive decline,” New England Journal of Medicine, vol. 348, no. 13, pp. 1215–1222, 2003. View at Publisher · View at Google Scholar · View at PubMed
  112. Y. Yakushiji, M. Nishiyama, S. Yakushiji et al., “Brain microbleeds and global cognitive function in adults without neurological disorder,” Stroke, vol. 39, no. 12, pp. 3323–3328, 2008. View at Publisher · View at Google Scholar · View at PubMed
  113. J. A. Schneider, “Brain microbleeds and cognitive function,” Stroke, vol. 38, no. 6, pp. 1730–1731, 2007. View at Publisher · View at Google Scholar · View at PubMed
  114. R. Camicioli, M. M. Moore, G. Sexton, D. B. Howieson, and J. A. Kaye, “Age-related brain changes associated with motor function in healthy older people,” Journal of the American Geriatrics Society, vol. 47, no. 3, pp. 330–334, 1999. View at Google Scholar
  115. C. R. Guttmann, R. Benson, S. K. Warfield et al., “White matter abnormalities in mobility-impaired older persons,” Neurology, vol. 54, no. 6, pp. 1277–1283, 2000. View at Google Scholar
  116. C. Rosano, J. Brach, W. T. Longstreth Jr., and A. B. Newman, “Quantitative measures of gait characteristics indicate prevalence of underlying subclinical structural brain abnormalities in high-functioning older adults,” Neuroepidemiology, vol. 26, no. 1, pp. 52–60, 2006. View at Publisher · View at Google Scholar · View at PubMed
  117. B. E. Maki, “Gait changes in older adults: predictors of falls or indicators of fear,” Journal of the American Geriatrics Society, vol. 45, no. 3, pp. 313–320, 1997. View at Google Scholar
  118. C. Rosano, J. Brach, S. Studenski, W. T. Longstreth Jr., and A. B. Newman, “Gait variability is associated with subclinical brain vascular abnormalities in high-functioning older adults,” Neuroepidemiology, vol. 29, no. 3-4, pp. 193–200, 2008. View at Publisher · View at Google Scholar · View at PubMed
  119. H. Baezner, C. Blahak, A. Poggesi et al., “Association of gait and balance disorders with age-related white matter changes: the LADIS Study,” Neurology, vol. 70, no. 12, pp. 935–942, 2008. View at Publisher · View at Google Scholar · View at PubMed
  120. D. P. Briley, M. Wasay, S. Sergent, and S. Thomas, “Cerebral white matter changes (leukoaraiosis), stroke, and gait disturbance,” Journal of the American Geriatrics Society, vol. 45, no. 12, pp. 1434–1438, 1997. View at Google Scholar
  121. H. C. Chui, C. Zarow, W. J. Mack et al., “Cognitive impact of subcortical vascular and Alzheimer's disease pathology,” Annals of Neurology, vol. 60, no. 6, pp. 677–687, 2006. View at Publisher · View at Google Scholar · View at PubMed
  122. V. Srikanth, R. Beare, L. Blizzard et al., “Cerebral white matter lesions, gait, and the risk of incident falls: a prospective population-based study,” Stroke, vol. 40, no. 1, pp. 175–180, 2009. View at Publisher · View at Google Scholar · View at PubMed
  123. V. Srikanth, T. G. Phan, J. Chen, R. Beare, J. M. Stapleton, and D. C. Reutens, “The location of white matter lesions and gait—A voxel-based study,” Annals of Neurology, vol. 67, no. 2, pp. 265–269, 2010. View at Publisher · View at Google Scholar · View at PubMed
  124. R. A. Bhadelia, L. L. Price, K. L. Tedesco et al., “Diffusion tensor imaging, white matter lesions, the corpus callosum, and gait in the elderly,” Stroke, vol. 40, no. 12, pp. 3816–3820, 2009. View at Publisher · View at Google Scholar · View at PubMed
  125. K. F. de Laat, A. M. Tuladhar, A. G. van Norden, D. G. Norris, M. P. Zwiers, and F. E. de Leeuw, “Loss of white matter integrity is associated with gait disorders in cerebral small vessel disease,” Brain, vol. 134, no. 1, pp. 73–83, 2011. View at Publisher · View at Google Scholar · View at PubMed
  126. K. F. de Laat, A. G. van Norden, R. A. Gons et al., “Diffusion tensor imaging and gait in elderly persons with cerebral small vessel disease,” Stroke, vol. 42, pp. 373–379, 2011. View at Publisher · View at Google Scholar · View at PubMed
  127. K. Iseki, T. Hanakawa, K. Hashikawa et al., “Gait disturbance associated with white matter changes: a gait analysis and blood flow study,” NeuroImage, vol. 49, no. 2, pp. 1659–1666, 2010. View at Publisher · View at Google Scholar · View at PubMed
  128. K. A. Jellinger, “The pathology of Parkinson's disease,” Advances in Neurology, vol. 86, pp. 55–72, 2001. View at Google Scholar
  129. N. I. Bohnen and R. L. Albin, “White matter lesions in Parkinson disease,” Nature Reviews Neurology, vol. 7, no. 4, pp. 229–236, 2011. View at Publisher · View at Google Scholar · View at PubMed
  130. L. C. Silbert and J. Kaye, “Neuroimaging and cognition in Parkinson's disease dementia,” Brain Pathology, vol. 20, no. 3, pp. 646–653, 2010. View at Publisher · View at Google Scholar · View at PubMed
  131. H. K. Kuo and L. A. Lipsitz, “Cerebral white matter changes and geriatric syndromes: is there a link?” Journals of Gerontology, vol. 59, no. 8, pp. 818–826, 2004. View at Google Scholar
  132. G. A. Kuchel, N. Moscufo, C. R. Guttmann et al., “Localization of brain white matter hyperintensities and urinary incontinence in community-dwelling older adults,” Journals of Gerontology, vol. 64, no. 8, pp. 902–909, 2009. View at Publisher · View at Google Scholar · View at PubMed
  133. K. Sonohara, K. Kozaki, M. Akishita et al., “White matter lesions as a feature of cognitive impairment, low vitality and other symptoms of geriatric syndrome in the elderly,” Geriatrics and Gerontology International, vol. 8, no. 2, pp. 93–100, 2008. View at Publisher · View at Google Scholar · View at PubMed
  134. A. Poggesi, G. Pracucci, H. Chabriat et al., “Urinary complaints in nondisabled elderly people with age-related white matter changes: the Leukoaraiosis And DISability (LADIS) Study,” Journal of the American Geriatrics Society, vol. 56, no. 9, pp. 1638–1643, 2008. View at Publisher · View at Google Scholar · View at PubMed
  135. Y. Y. Sitoh, Y. Y. Sitoh, and S. Sahadevan, “Clinical significance of cerebral white matter lesions in older Asians with suspected dementia,” Age and Ageing, vol. 33, no. 1, pp. 67–71, 2004. View at Google Scholar
  136. S. D. Tadic, D. Griffiths, A. Murrin, W. Schaefer, H. J. Aizenstein, and N. M. Resnick, “Brain activity during bladder filling is related to white matter structural changes in older women with urinary incontinence,” NeuroImage, vol. 51, no. 4, pp. 1294–1302, 2010. View at Publisher · View at Google Scholar · View at PubMed
  137. I. M. Lesser, E. Hill-Gutierrez, B. L. Miller, and K. B. Boone, “Late-onset depression with white matter lesions,” Psychosomatics, vol. 34, no. 4, pp. 364–367, 1993. View at Google Scholar
  138. R. D. Nebes, C. F. Reynolds Jr., F. Boada et al., “Longitudinal increase in the volume of white matter hyperintensities in late-onset depression,” International Journal of Geriatric Psychiatry, vol. 17, no. 6, pp. 526–530, 2002. View at Publisher · View at Google Scholar · View at PubMed
  139. D. C. Steffens, H. B. Bosworth, J. M. Provenzale, and J. R. MacFall, “Subcortical white matter lesions and functional impairment in geriatric depression,” Depression and Anxiety, vol. 15, no. 1, pp. 23–28, 2002. View at Publisher · View at Google Scholar · View at PubMed
  140. A. Teodorczuk, J. T. O'Brien, M. J. Firbank et al., “White matter changes and late-life depressive symptoms: longitudinal study,” British Journal of Psychiatry, vol. 191, no. 3, pp. 212–217, 2007. View at Publisher · View at Google Scholar · View at PubMed
  141. O. Godin, C. Dufouil, P. Maillard et al., “White matter lesions as a predictor of depression in the elderly: the 3C-dijon study,” Biological Psychiatry, vol. 63, no. 7, pp. 663–669, 2008. View at Publisher · View at Google Scholar · View at PubMed
  142. L. L. Herrmann, M. Le Masurier, and K. P. Ebmeier, “White matter hyperintensities in late life depression: a systematic review,” Journal of Neurology, Neurosurgery and Psychiatry, vol. 79, no. 6, pp. 619–624, 2008. View at Publisher · View at Google Scholar · View at PubMed
  143. J. J. Vattakatuchery and J. Joy, “Hyperintensities on MRI: white matter and depression,” British Medical Journal, vol. 341, Article ID c4611, 2010. View at Publisher · View at Google Scholar
  144. P. J. Olesen, D. R. Gustafson, M. Simoni et al., “Temporal lobe atrophy and white matter lesions are related to major depression over 5 years in the elderly,” Neuropsychopharmacology, vol. 35, no. 13, pp. 2638–2645, 2010. View at Publisher · View at Google Scholar · View at PubMed
  145. W. K. Tang, Y. K. Chen, J. Y. Lu et al., “White matter hyperintensities in post-stroke depression: a case control study,” Journal of Neurology, Neurosurgery & Psychiatry, vol. 81, no. 12, pp. 1312–1315, 2010. View at Publisher · View at Google Scholar · View at PubMed
  146. J. H. Fu, K. Wong, V. Mok et al., “Neuroimaging predictors for depressive symptoms in cerebral small vessel disease,” International Journal of Geriatric Psychiatry, vol. 25, no. 10, pp. 1039–1043, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  147. K. R. Cullen, B. Klimes-Dougan, R. Muetzel et al., “Altered white matter microstructure in adolescents with major depression: a preliminary study,” Journal of the American Academy of Child and Adolescent Psychiatry, vol. 49, no. 2, pp. 173–183, 2010. View at Publisher · View at Google Scholar · View at Scopus
  148. J. F. Buyck, C. Dufouil, B. Mazoyer et al., “Cerebral white matter lesions are associated with the risk of stroke but not with other vascular events: the 3-city dijon study,” Stroke, vol. 40, no. 7, pp. 2327–2331, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  149. H. Bokura, S. Kobayashi, S. Yamaguchi et al., “Silent brain infarction and subcortical white matter lesions increase the risk of stroke and mortality: a prospective cohort study,” Journal of Stroke and Cerebrovascular Diseases, vol. 15, no. 2, pp. 57–63, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  150. N. K. Oksala, A. Oksala, T. Pohjasvaara et al., “Age related white matter changes predict stroke death in long term follow-up,” Journal of Neurology, Neurosurgery and Psychiatry, vol. 80, no. 7, pp. 762–766, 2009. View at Publisher · View at Google Scholar · View at PubMed
  151. D. Inzitari, M. Cadelo, M. L. Marranci, G. Pracucci, and L. Pantoni, “Vascular deaths in elderly neurological patients with leukoaraiosis,” Journal of Neurology Neurosurgery and Psychiatry, vol. 62, no. 2, pp. 177–181, 1997. View at Google Scholar
  152. V. Palumbo, J. M. Boulanger, M. D. Hill, D. Inzitari, and A. M. Buchan, “Leukoaraiosis and intracerebral hemorrhage after thrombolysis in acute stroke,” Neurology, vol. 68, no. 13, pp. 1020–1024, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  153. T. Neumann-Haefelin, S. Hoelig, J. Berkefeld et al., “Leukoaraiosis is a risk factor for symptomatic intracerebral hemorrhage after thrombolysis for acute stroke,” Stroke, vol. 37, no. 10, pp. 2463–2466, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  154. R. H. Swartz and R. Z. Kern, “Migraine is associated with magnetic resonance imaging white matter abnormalities: a meta-analysis,” Archives of Neurology, vol. 61, no. 9, pp. 1366–1368, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  155. M. C. Kruit, M. A. van Buchem, L. J. Launer, G. M. Terwindt, and M. D. Ferrari, “Migraine is associated with an increased risk of deep white matter lesions, subclinical posterior circulation infarcts and brain iron accumulation: the population-based MRI CAMERA study,” Cephalalgia, vol. 30, no. 2, pp. 129–136, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  156. N. Colledge, S. Lewis, G. Mead, R. Sellar, J. Wardlaw, and J. Wilson, “Magnetic resonance brain imaging in people with dizziness: a comparison with non-dizzy people,” Journal of Neurology Neurosurgery and Psychiatry, vol. 72, no. 5, pp. 587–589, 2002. View at Publisher · View at Google Scholar
  157. G. J. Hankey and J. W. Eikelboom, “Homocysteine and vascular disease,” The Lancet, vol. 354, no. 9176, pp. 407–413, 1999. View at Publisher · View at Google Scholar · View at Scopus
  158. G. N. Welch and J. Loscalzo, “Homocysteine and atherothrombosis,” New England Journal of Medicine, vol. 338, no. 15, pp. 1042–1050, 1998. View at Publisher · View at Google Scholar · View at Scopus
  159. F. Perini, E. Galloni, I. Bolgan et al., “Elevated plasma homocysteine in acute stroke was not associated with severity and outcome: stronger association with small artery disease,” Neurological Sciences, vol. 26, no. 5, pp. 310–318, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  160. S. E. Vermeer, E. J. van Dijk, P. J. Koudstaal et al., “Homocysteine, silent brain infarcts, and white matter lesions: the Rotterdam scan study,” Annals of Neurology, vol. 51, no. 3, pp. 285–289, 2002. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  161. C. Dufouil, A. Alperovitch, V. Ducros, and C. Tzourio, “Homocysteine, white matter hyperintensities, and cognition in healthy elderly people,” Annals of Neurology, vol. 53, no. 2, pp. 214–221, 2003. View at Publisher · View at Google Scholar · View at PubMed
  162. W. T. Longstreth Jr., R. Katz, J. Olson et al., “Plasma total homocysteine levels and cranial magnetic resonance imaging findings in elderly persons: the cardiovascular health study,” Archives of Neurology, vol. 61, no. 1, pp. 67–72, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  163. A. Hassan, B. J. Hunt, M. O'Sullivan et al., “Homocysteine is a risk factor for cerebral small vessel disease, acting via endothelial dysfunction,” Brain, vol. 127, no. 1, pp. 212–219, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  164. P. Sachdev, R. Parslow, C. Salonikas et al., “Homocysteine and the brain in midadult life: evidence for an increased risk of leukoaraiosis in men,” Archives of Neurology, vol. 61, no. 9, pp. 1369–1376, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  165. T. M. Scott, K. L. Tucker, A. Bhadelia et al., “Homocysteine and B vitamins relate to brain volume and white-matter changes in geriatric patients with psychiatric disorders,” American Journal of Geriatric Psychiatry, vol. 12, no. 6, pp. 631–638, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  166. C. B. Wright, M. C. Paik, T. R. Brown et al., “Total homocysteine is associated with white matter hyperintensity volume: the Northern Manhattan study,” Stroke, vol. 36, no. 6, pp. 1207–1211, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  167. A. Wong, V. Mok, Y. H. Fan, W. W. Lam, K. S. Liang, and K. S. Wong, “Hyperhomocysteinemia is associated with volumetric white matter change in patients with small vessel disease,” Journal of Neurology, vol. 253, no. 4, pp. 441–447, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  168. B. Censori, T. Partziguian, O. Manara, and M. Poloni, “Plasma homocysteine and severe white matter disease,” Neurological Sciences, vol. 28, no. 5, pp. 259–263, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  169. J. L. Fuh, “Homocysteine, cognition and brain white matter hyperintensities,” Acta Neurologica Taiwanica, vol. 19, no. 3, pp. 150–152, 2010. View at Google Scholar
  170. S. Seshadri, P. A. Wolf, A. S. Beiser et al., “Association of plasma total homocysteine levels with subclinical brain injury: cerebral volumes, white matter hyperintensity, and silent brain infarcts at volumetric magnetic resonance imaging in the Framingham Offspring Study,” Archives of Neurology, vol. 65, no. 5, pp. 642–649, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  171. F. Anan, T. Masaki, H. Tatsukawa et al., “The role of homocysteine as a significant risk factor for white matter lesions in Japanese women with rheumatoid arthritis,” Metabolism, vol. 58, no. 1, pp. 69–73, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  172. Y. L. Tseng, Y. Y. Chang, J. S. Liu, C. S. Su, S. L. Lai, and M. Y. Lan, “Association of plasma homocysteine concentration with cerebral white matter hyperintensity on magnetic resonance images in stroke patients,” Journal of the Neurological Sciences, vol. 284, no. 1-2, pp. 36–39, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  173. H. S. Markus, B. Hunt, K. Palmer, C. Enzinger, H. Schmidt, and R. Schmidt, “Markers of endothelial and hemostatic activation and progression of cerebral white matter hyperintensities: longitudinal results of the Austrian Stroke Prevention Study,” Stroke, vol. 36, no. 7, pp. 1410–1414, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  174. J. H. Han, K. S. Wong, Y. Y. Wang, J. H. Fu, D. Ding, and Z. Hong, “Plasma level of sICAM-1 is associated with the extent of white matter lesion among asymptomatic elderly subjects,” Clinical Neurology and Neurosurgery, vol. 111, no. 10, pp. 847–851, 2009. View at Publisher · View at Google Scholar · View at PubMed
  175. R. Schmidt, H. Schmidt, M. Pichler et al., “C-reactive protein, carotid atherosclerosis, and cerebral small-vessel disease: results of the austrian stroke prevention study,” Stroke, vol. 37, no. 12, pp. 2910–2916, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  176. E. J. van Dijk, N. D. Prins, S. E. Vermeer et al., “C-reactive protein and cerebral small-vessel disease: the Rotterdam scan study,” Circulation, vol. 112, no. 6, pp. 900–905, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  177. M. Fornage, Y. A. Chiang, E. S. Omeara et al., “Biomarkers of inflammation and MRI-defined small vessel disease of the brain: the cardiovascular health study,” Stroke, vol. 39, no. 7, pp. 1952–1959, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  178. C. Dufouil, J. Chalmers, O. Coskun et al., “Effects of blood pressure lowering on cerebral white matter hyperintensities in patients with stroke: the PROGRESS (Perindopril Protection Against Recurrent Stroke Study) Magnetic Resonance Imaging Substudy,” Circulation, vol. 112, no. 11, pp. 1644–1650, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  179. L. Pantoni, M. Carosi, S. Amigoni, M. Mascalchi, and D. Inzitari, “A preliminary open trial with nimodipine in patients with cognitive impairment and leukoaraiosis,” Clinical Neuropharmacology, vol. 19, no. 6, pp. 497–506, 1996. View at Google Scholar
  180. L. Pantoni, R. Rossi, D. Inzitari et al., “Efficacy and safety of nimodipine in subcortical vascular dementia: a subgroup analysis of the Scandinavian Multi-Infarct Dementia Trial,” Journal of the Neurological Sciences, vol. 175, no. 2, pp. 124–134, 2000. View at Publisher · View at Google Scholar
  181. L. Pantoni, T. del Ser, A. G. Soglian et al., “Efficacy and safety of nimodipine in subcortical vascular dementia: a randomized placebo-controlled trial,” Stroke, vol. 36, no. 3, pp. 619–624, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  182. F. Amenta, A. Lanari, F. Mignini, G. Silvestrelli, E. Traini, and D. Tomassoni, “Nicardipine use in cerebrovascular disease: a review of controlled clinical studies,” Journal of the Neurological Sciences, vol. 283, no. 1-2, pp. 219–223, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  183. K. Kario, T. Matsuo, H. Kobayashi, M. Imiya, M. Matsuo, and K. Shimada, “Nocturnal fall of blood pressure and silent cerebrovascular damage in elderly hypertensive patients: advanced silent cerebrovascular damage in extreme dippers,” Hypertension, vol. 27, no. 1, pp. 130–135, 1996. View at Google Scholar · View at Scopus
  184. T. R. Pedersen, “Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S),” The Lancet, vol. 344, no. 8934, pp. 1383–1389, 1994. View at Google Scholar · View at Scopus
  185. C. Bernick, R. Katz, N. L. Smith et al., “Statins and cognitive function in the elderly: the Cardiovascular Health Study,” Neurology, vol. 65, no. 9, pp. 1388–1394, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  186. D. Woo, B. M. Kissela, J. C. Khoury et al., “Hypercholesterolemia, HMG-CoA reductase inhibitors, and risk of intracerebral hemorrhage: a case-control study,” Stroke, vol. 35, no. 6, pp. 1360–1364, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  187. J. Roquer, A. Rodriguez Campello, M. Gomis, A. Ois, E. Munteis, and P. Bohm, “Serum lipid levels and in-hospital mortality in patients with intracerebral hemorrhage,” Neurology, vol. 65, no. 8, pp. 1198–1202, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  188. H. Kavirajan and L. S. Schneider, “Efficacy and adverse effects of cholinesterase inhibitors and memantine in vascular dementia: a meta-analysis of randomised controlled trials,” The Lancet Neurology, vol. 6, no. 9, pp. 782–792, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  189. H. J. Mobius and A. Stoffler, “New approaches to clinical trials in vascular dementia: memantine in small vessel disease,” Cerebrovascular Diseases, vol. 13, supplement 2, pp. 61–66, 2002. View at Publisher · View at Google Scholar
  190. M. Dichgans, H. S. Markus, S. Salloway et al., “Donepezil in patients with subcortical vascular cognitive impairment: a randomised double-blind trial in CADASIL,” The Lancet Neurology, vol. 7, no. 4, pp. 310–318, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  191. G. C. Roman, S. Salloway, S. E. Black et al., “Randomized, placebo-controlled, clinical trial of donepezil in vascular dementia: differential effects by hippocampal size,” Stroke, vol. 41, no. 6, pp. 1213–1221, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  192. The VITATOPS Trial Study Group, “B vitamins in patients with recent transient ischaemic attack or stroke in the VITAmins TO Prevent Stroke (VITATOPS) trial: a randomised, double-blind, parallel, placebo-controlled trial,” The Lancet Neurology, vol. 9, no. 9, pp. 855–865, 2010. View at Publisher · View at Google Scholar